The Food and Drug Administration (FDA) is expected to discuss relaxing restrictions on several peptide injections in an upcoming meeting, potentially making these substances more accessible for compounding by pharmacies. This move aligns with Health and Human Services Secretary Robert F. Kennedy Jr.'s advocacy for deregulation of peptides, which are used for various medical conditions and have gained popularity in wellness circles.
FDA Reportedly Considering Easing Peptide Restrictions
